Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Circular With Special Resolutions

23 Jul 2012 15:15

RNS Number : 2903I
J.P. Morgan Private Equity Ltd
23 July 2012
 



 

JPEL PUBLISHES CIRCULAR WITH SPECIAL RESOLUTIONS

 

* * *

 

GUERNSEY, 23 JULY 2012

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") has today published a circular to Shareholders.

 

The circular contains notices in respect of the 2012 AGM of the Company and class meetings of holders of US$ Equity Shares and each class of ZDP Shares. The meetings will be held at 3:30 p.m. (London time) on 5 September 2012 at Carinthia House, 9 -12 The Grange, St Peter Port, Guernsey GY1 4BF.

 

Details of the resolutions proposed at each of the meetings are set out in the circular. JPEL's Board of Directors (the "Board") would like to highlight that the following special resolution will be proposed to the Company as a whole at the AGM and to each class of shareholders at the relevant class meeting:

·; Amend the limits on borrowing to 30 per. cent of the Total Assets of the Company.

·; Amend the final capital entitlement dates of each of the Company's three classes of ZDP Shares. JPEL proposes that each final capital entitlement date be moved forward by two months but that each final capital entitlement will remain the same.

·; Increase the minimum cover under the ZDP Test from 1.3 times to 2.0 times, as defined in the Company's Articles.

The implementation of the changes described above is conditional on approval of the relevant resolutions at each of the AGM and each of the class meetings.

The Board would also like to highlight the following resolution to be proposed at the US$ Equity Share Class Meeting:

·; Approve the refinancing proposal for the Company's 2013 ZDP Shares. JPEL proposes that the Company's 2013 ZDP Shares be refinanced primarily through a combination of available cash and undrawn borrowings under the existing credit facility.

 

JPEL's Board is focused on the optimisation of the Company's capital structure. The Board believes that the combination of all ordinary, special and extraordinary resolutions proposed at the meetings referred to in the circular will provide JPEL with maximum flexibility to efficiently manage its capital structure.

 

Copies of the following documents are available for inspection at the offices of Herbert Smith LLP, Exchange House, Primrose Street, London EC2A 2HS, at the registered office of the Company during normal business hours of any business day (Saturdays and public holidays excepted) until the conclusion of the class meetings referred to in the circular and at the place of the AGM for 15 minutes prior to the AGM until the conclusion of the class meetings referred to in the circular:

 

·; the current Memorandum of Incorporation and the Articles of Incorporation;

·; the proposed amendments to the Articles of Incorporation; and

·; the AGM circular.

 

Colour-coded copies of the circular and proxy form will be mailed to shareholders.

 

Copies of the circular and proxy form have been submitted to the National Storage Mechanism and will shortly be available for inspection at:

http://www.morningstar.co.uk/uk/NSM.

 

A full copy of the circular and annual report and accounts are available on JPEL's website (through http://www.jpelonline.com/investor-information/shareholder_documents/2012.aspx).

 

 

Further copies of this document may be obtained, free of charge, from the registered office of the Company and from:

 

J.P. Morgan Asset Management

20 Finsbury Street

London

EC2Y 9AQ

United Kingdom

 

J.P. Morgan Asset Management

270 Park Avenue

New York, NY 10017

USA

 

 

 

* * *

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

 

END

 

For further information please contact:

 

J.P. Morgan Private Equity Limited

Troy Duncan / Greg Getschow

Troy.Duncan@jpmorgan.com / Gregory.Getschow@jpmorgan.com

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCRJMITMBBTBIT
Date   Source Headline
28th Sep 20181:10 pmRNSAnnual Financial Report - 30 June 2018
17th Sep 20187:00 amRNSNet Asset Value(s) - June 2018
22nd Aug 20185:11 pmRNSHolding(s) in Company
20th Jul 20187:00 amRNSNet Asset Value(s) - May 2018
3rd Jul 20187:00 amRNSNet Asset Value(s) - April 2018
9th May 20187:00 amRNSNet Asset Value(s) - March 2018
13th Apr 20189:30 amRNSNet Asset Value(s) - February 2018
11th Apr 20187:00 amRNSNotice to Shareholders - Total Voting Rights
10th Apr 20182:24 pmRNSCompletion of Fourth Mandatory Redemption
22nd Mar 20187:00 amRNSHalf-year Report - 31 December 2017
22nd Mar 20187:00 amRNSMandatory Redemption- US$Equity Shares -April 2018
12th Mar 20187:00 amRNSNet Asset Value(s) - January 2018
2nd Feb 20187:00 amRNSNet Asset Value(s) - December 2017
15th Jan 20187:00 amRNSNet Asset Value(s) - November 2017
29th Dec 20171:15 pmRNSNotice to Shareholders - Key Information Document
14th Dec 20175:50 pmRNSNotice to Shareholders - Total Voting Rights
14th Dec 20177:00 amRNSCompletion Of Third Mandatory Redemption
4th Dec 20172:52 pmRNSAGM Results
4th Dec 20179:44 amRNSNet Asset Value(s) - October 2017 Review
1st Dec 20177:05 amRNSMandatory Redemption - US$Equity Shares - Dec 2017
1st Dec 20177:00 amRNSNet Asset Value(s) - October 2017
24th Nov 20177:00 amRNSSale of Celerion
20th Nov 20172:59 pmRNSHolding(s) in Company
15th Nov 201710:11 amRNSRetirement of 2017 ZDP Shares
9th Nov 20177:00 amRNS2017 AGM CIRCULAR
27th Oct 20174:33 pmRNSHolding(s) in Company
27th Oct 20177:00 amRNSNet Asset Value(s) - September 2017
17th Oct 20179:40 amRNSDirector Declaration
13th Oct 20177:00 amRNSTiming of Retirement of 2017 ZDP Shares
11th Oct 20177:00 amRNSBerkshire Partners Acquires Accela
28th Sep 20177:00 amRNSAnnual Financial Report
27th Sep 20179:45 amRNSDirector Update
26th Sep 201711:11 amRNSNet Asset Value(s) - August 2017
7th Sep 20177:00 amRNSNet Asset Value(s) - July 2017
21st Aug 20172:21 pmRNSHolding(s) in Company
3rd Aug 20177:00 amRNSNet Asset Value(s) - June 2017
5th Jul 20175:50 pmRNSNet Asset Value(s) - May 2017 Correction
30th Jun 20179:52 amRNSNet Asset Value(s) - May 2017
2nd Jun 20177:00 amRNSNet Asset Value(s) - April 2017
30th May 20174:34 pmRNSHolding(s) in Company
25th May 20174:42 pmRNSHolding(s) in Company
2nd May 20173:50 pmRNSNotice to Shareholders - Total Voting Rights
2nd May 20177:00 amRNSCompletion of Mandatory Redemption_ April 2017
24th Apr 20176:15 pmRNSNotification of Dealings in Shares
21st Apr 20177:00 amRNSQuarter End Review for March 2017
12th Apr 20177:00 amRNSMandatory Redemption_US$ Equity Shares_April 2017
11th Apr 20175:22 pmRNSNet Asset Value(s) - March 2017
7th Apr 20177:00 amRNSNet Asset Value(s) - February 2017
28th Mar 20174:56 pmRNSHalf-year Report
16th Mar 20176:04 pmRNSSale of Datamars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.